A decreased RIPK3 expression has also been reported in samples from human patients with cancer, such as breast cancer [7, 65], colorectal cancer [12, 66], acute myeloid leukemia (AML) [11, 68] and melanoma [69]. Here, RIPK3 is linked to colorectal cancer.